Key clinical point:
Major finding: Antenatal betamethasone treatment was linked to $4,681 per mother-infant pair, compared with $5,379 without corticosteroids (P = .02 for $698 difference).
Study details: The findings are based on a secondary analysis of a randomized clinical trial from October 2010 to February 2015 involving 2,821 mothers at high risk for preterm birth, and their infants.
Disclosures: The National Institutes of Health funded the research. Dr. Gyamfi-Bannerman received a grant from AMAG pharmaceuticals during the conduct of the study.
Gyamfi-Bannerman C. JAMA Pediatr. 2019 Mar 11.